- Home
- / Baylor Scott & White Health
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Baylor Scott & White Health financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Revenue
$10.5 B
FY, 2020
CreditSafe Score
?
Score changed on Jan 24, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 9.5B | 10.1B | 10.5B |
| Revenue growth, % | 4.0% | 6.1% | 4.7% |
| Operating expense total | 8.9B | 9.3B | 10.0B |
| Depreciation and amortization | 379.2M | 415.0M | 429.0M |
| EBIT | 582.3M | 725.0M | 559.0M |
| EBIT margin, % | 6.1% | 7.2% | 5.3% |
| Investment income | 253.4M | 253.0M | 227.0M |
| Pre tax profit | 866.4M | 864.0M | 463.0M |
| Income tax expense | 25.3M | 15.0M | 10.0M |
| Net Income | 754.8M | 538.0M | 114.0M |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |